Photoaffinity enabled transcriptome-wide identification of splice modulating small molecule–RNA binding events in native cells
Splice modulating small molecules have been developed to promote the U1 snRNP to engage with pre-mRNAs with strong and altered sequence preference. Transcriptomic profiling of bulk RNA from compound treated cells enables detection of RNAs impacted; however, it is difficult to delineate whether transcriptional changes are a consequence of direct compound treatment or <i>trans</i>-acting effects. To identify RNA targets that bind directly with splice modulating compounds, we deployed a photoaffinity labeling (PAL)-based Chem-CLIP approach. Through this workflow, we identify the telomerase lncRNA (TERC) as a previously unknown target of this class of clinically relevant small molecules. Using cellular ΔSHAPE-MaP, we orthogonally validate and further define the compound binding site as likely to be the conserved CR4/5 domain. Additionally, a thorough analysis of the PAL-based Chem-CLIP data reveals that considering competed RNAs, irrespective of magnitude of enrichment, adds a rich dimension of hit calling.
Authors
- Andrea Byrnes
- Lynn M. McGregor (ORCID: https://orcid.org/0000-0003-4310-2384)
- Jason R. Thomas (ORCID: https://orcid.org/0000-0001-7502-3600)
- Raven Shah (ORCID: https://orcid.org/0000-0001-9002-7298)
- Wanlin Yan
- Fan Yu Lin (ORCID: https://orcid.org/0000-0002-9435-5181)
- Joyce Rigal
- Andrew Krueger
- Nicole Renaud
- Steve Mullin
Institutions
- Novartis (Switzerland) (CH)
- Novartis (China) (CN)
Publication Details
- Journal
- RSC Chemical Biology
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1039/d4cb00266k
- Citations
- 1
- Primary Topic
- RNA Research and Splicing
- Type
- article
- Field-Weighted Citation Impact
- 0.81